Skip to content

Study the assosciation of severity of acanthosis nigricans with the metabolic syndrome

Study of metabolic syndrome in patients with acanthosis nigricans.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/05/042703
Enrollment
100
Registered
2022-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L83- Acanthosis nigricans

Interventions

None listed

Sponsors

Pandit BD Sharma PGIMS Rohtak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Acanthosis Nigricans aged >=18 years and comprising of both sexes.

Exclusion criteria

Exclusion criteria: 1) Patients with a history of intake of drugs which may lead to development of AN such as nicotinic acid, oral contraceptives, systemic steroids, diethylstilbestrol, antiretroviral drugs, and application of topical fusidic acid. 2) Patients with pregnancy and in the postpartum period up to 6 months. 3) Patients with family history of diabetes, hypertension and familial dyslipidemia, 4) Patients with history of endocrine diseases like Cushing syndrome, acromegaly, pheochromocytoma, hyperthyroidism, glucagonoma. 5) Participants with history of smoking and alcohol use. 6) Patients with skin diseases that are known to be associated with metabolic syndrome such as psoriasis, lichen planus, androgenic alopecia, acne, systemic lupus erythematous, vitilgo etc. 7) Patients with family history of acanthosis nigricans. 8) Patients on drugs known to cause hypertension, hyperglycemia and hyperlipidemia.

Design outcomes

Primary

MeasureTime frame
To study clinical features of patients with acanthosis nigricansTimepoint: 1 year

Secondary

MeasureTime frame
Association of metabolic syndrome with extent and severity of Acanthosis NigricansTimepoint: 1 year

Countries

India

Contacts

Public ContactChinmay Kumar Mandal

Pandit BD Sharma, PGIMS, Rohtak

drkamalaggarwal@live.in9416357200

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026